Ikarian Capital »

Zura Bio shares owned by Ikarian Capital

Quarter-by-quarter ownership of Zura Bio (ZURA) shares owned by Ikarian Capital from 13F filings

Historical chart of Ikarian Capital investment in Zura Bio

Tip: Access up to 7 years of quarterly data

All positions including Zura Bio held by Ikarian Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Zura Bio by Ikarian Capital

Quarter filed Position value Share count Share price at filing
2025-09-30 $9.2M 2.1M 4.33

More positions owned by Ikarian Capital

United Therapeutics Corporation Put Option (UTHR)
Spdr Series Trust S&p Biotech Put Option (XBI)
Genmab A/s Sponsored Ads (GMAB)
Bristol Myers Squibb Put Option (BMY)
Abivax Sa Sponsored Ads (ABVX)
Uniqure Nv Call Call Option
Insmed Com Par $.01 (INSM)
Ptc Therapeutics I (PTCT)
Ionis Pharmaceuticals (IONS)
Cidara Therapeutics Com New (CDTX)
Scholar Rock Hldg Corp Put Option (SRRK)
Rapt Therapeutics Com New (RAPT)
Maze Therapeatics (MAZE)
Soleno Therapeutics (SLNO)
Cytokinetics Com New (CYTK)

View all positions for Ikarian Capital

Top funds holding Zura Bio

Suvretta Capital Management
VR Adviser
Jpmorgan Chase & Co
Dr. Jeffrey R. Jay, M.D.
Adage Capital Partners GP
Pfizer
Braidwell
Ikarian Capital
Armistice Capital
Affinity Asset Advisors
Boothbay Fund Management
Point72 Asset Management
Silverarc Capital Management
ADAR1 Capital Management
Millennium Management

View all funds holding Zura Bio